chevron-down Created with Sketch Beta.
June 17, 2022

New Mexico Becomes Latest State to Settle Pharmacy Overcharge and Price Transparency Claims with Centene Corporation

On June 13, New Mexico Attorney General Hector Balderes announced a $13.7M settlement with Centene Corporation. The settlement resolved the Attorney General’s investigation of Centene’s subsidiaries in their role as Pharmacy Benefit Managers (PBMs) servicing the state’s Medicaid drug program. The Attorney General alleged that Centene overcharged the program by layering fees and not passing on retail discounts. As part of the settlement, Centene has agreed to provide price transparency on the pharmaceutical benefits and services it provides to the state’s Medicaid program going forward. The settlement is the latest in a string of settlements between Centene and states that have initiated investigations or lawsuits against Centene’s PBMs.  

The material in all ABA publications is copyrighted and may be reprinted by permission only. Request reprint permission here.